SMS Pharmaceuticals Ltd Q2 FY26 consolidated PAT increases to Rs. 25.31 crores

SMS Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2025.

Financial Results (Q2 FY2026) - QoQ Comparison

The company has reported total income of Rs. 243.8634 crores during the period ended September 30, 2025 as compared to Rs. 196.6402 crores during the period ended June 30, 2025.

The company has posted net profit / (loss) of Rs. 25.3127 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 20.4905 crores for the period ended June 30, 2025.

The company has reported EPS of Rs. 2.84 for the period ended September 30, 2025 as compared to Rs. 2.31 for the period ended June 30, 2025.

Financials	Q2 FY2026	Q1 FY2026	% Change
Total Income	₹ 243.8634 crs	₹196.6402 crs	24.02%
Net Profit	₹25.3127 crs	₹20.4905 crs	23.53%
EPS	₹2.84	₹2.31	22.94%

Financial Results (Q2 FY2026) - YoY Comparison

The company has reported total income of Rs. 243.8634 crores during the period ended September 30, 2025 as compared to Rs.198.0525 crores during the period ended September 30, 2024.

The company has posted net profit / (loss) of Rs.25.3127 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.14.0991 crores for the period ended September 30, 2024.

The company has reported EPS of Rs.2.84 for the period ended September 30, 2025 as compared to Rs.1.67 for the period ended September 30, 2024.

Financials	Q2 FY2026	Q2 FY2025	% Change
Total Income	₹ 243.8634 crs	₹198.0525 crs	23.13%
Net Profit	₹25.3127 crs	₹14.0991 crs	79.53%
EPS	₹2.84	₹1.67	70.06%

Financial Results (Half Year Ended FY2026) - YoY Comparison

The company has reported total income of Rs.440.5036 crores during the 6 Months period ended September 30, 2025 as compared to Rs.363.8715 crores during the 6 Months period ended September 30, 2024.

The company has posted net profit / (loss) of Rs.45.8032 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.30.5785 crores for the 6 Months period ended September 30, 2024.

The company has reported EPS of Rs.5.13 for the 6 Months period ended September 30, 2025 as compared to Rs.3.61 for the 6 Months period ended September 30, 2024.

Financials	Half Year Ended FY2026	Half Year Ended FY2025	% Change
Total Income	₹440.5036 crs	₹363.8715 crs	21.06%
Net Profit	₹45.8032 crs	₹30.5785 crs	49.79%
EPS	₹5.13	₹3.61	42.11%

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 288.80 as compared to the previous close of Rs. 284.00. The total number of shares traded during the day was 9006 in over 379 trades.

The stock hit an intraday high of Rs. 290.40 and intraday low of 276.00. The net turnover during the day was Rs. 2572802.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals Q2FY26 Q2FY2026 H1FY26 H1FY2026 ResultUpdate